NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NASDAQ: PSTI) (DAX: PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced that Mr. Zami Aberman, Pluristem's President & CEO, will be the keynote speaker at the 4th Annual Stem Cells Asia Congress held in Singapore, June 25-26, 2008. Mr. Aberman will present on June 26 at 3:05 pm. The title of the presentation is: "Novel Allogeneic Cell Therapy using PLacental eXpanded (PLX) Mesenchymal Stromal Cells, Grown in a 3D Culture."
